Molecular Typing and Resistance Profiles of Vancomycin-Intermediate Staphylococcus aureus in Korea: Results from a National Surveillance Study, 2007-2013

Background: To investigate the national molecular epidemiology and resistance profiles of vancomycinintermediate Staphylococcus aureus (VISA), we analyzed the characteristics of methicillin-resistant Staphylococcus aureus (MRSA) collected from clinical samples at tertiary or general hospitals partic...

Full description

Saved in:
Bibliographic Details
Published inAnnals of clinical microbiology Vol. 19; no. 4; pp. 88 - 96
Main Authors Kim, Jung Wook, Kang, Gi Su, Yoo, Jae Il, Kim, Hwa Su, Lee, Yeong Seon, Yu, Jae-Yon, Lee, Kwang-Jun, Park, Chan, Kim, Il-Hwan
Format Journal Article
LanguageEnglish
Published 대한임상미생물학회 01.12.2016
Subjects
Online AccessGet full text
ISSN2288-0585
2288-0585
2288-6850
DOI10.5145/ACM.2016.19.4.88

Cover

Abstract Background: To investigate the national molecular epidemiology and resistance profiles of vancomycinintermediate Staphylococcus aureus (VISA), we analyzed the characteristics of methicillin-resistant Staphylococcus aureus (MRSA) collected from clinical samples at tertiary or general hospitals participating in a nationwide surveillance program for VISA and vancomycin-resistant Staphylococcus aureus (VRSA) in Korea during an 12-week period in each year from 2007 to 2013. Methods: VISA was defined by agar dilution, broth dilution and E-test methods with vancomycin minimum inhibitory concentrations of >2 μg/mL. All VISA isolates were characterized by multilocus sequence typing, staphylococcal cassette chromosome mec typing, spa typing, accessory gene regulator typing, Diversilab analysis, and antibiogram analysis. Results: Of 109,345 MRSA isolates, 87,354 were screened and 426 isolates were identified as positive on brain heart infusion agar containing 4 μg/mL vancomycin (BHI-V4). Of 426 isolates, 76 isolates were identified as VISA. No VRSA isolates were detected among the isolates. Overall, a total of 6 genotypes were identified among VISA strains and the predominant clones were ST5-II-t2460, ST72-IV-t324, and ST239-III-t037 (44.7%, 15.8%, and 10.5%, respectively). Of note, ST72-IV-t324 clones are known to be a typical community-associated MRSA. ST239-IIIt037 strains were more resistant to trimethoprim-sulfamethoxazole than any other type of strain. ST72- IV-t324 strains were susceptible to all of the antimicrobial agents tested except erythromycin and daptomycin. All of the VISA isolates were susceptible to linezolid and quinupristin-dalfopristin. Conclusion: Although VRSA is still rare, continuous monitoring of VRSA occurrence is needed, as well as VISA prevalence, epidemic clonal shift, and antimicrobial resistance. KCI Citation Count: 0
AbstractList Background: To investigate the national molecular epidemiology and resistance profiles of vancomycinintermediate Staphylococcus aureus (VISA), we analyzed the characteristics of methicillin-resistant Staphylococcus aureus (MRSA) collected from clinical samples at tertiary or general hospitals participating in a nationwide surveillance program for VISA and vancomycin-resistant Staphylococcus aureus (VRSA) in Korea during an 12-week period in each year from 2007 to 2013. Methods: VISA was defined by agar dilution, broth dilution and E-test methods with vancomycin minimum inhibitory concentrations of >2 μg/mL. All VISA isolates were characterized by multilocus sequence typing, staphylococcal cassette chromosome mec typing, spa typing, accessory gene regulator typing, Diversilab analysis, and antibiogram analysis. Results: Of 109,345 MRSA isolates, 87,354 were screened and 426 isolates were identified as positive on brain heart infusion agar containing 4 μg/mL vancomycin (BHI-V4). Of 426 isolates, 76 isolates were identified as VISA. No VRSA isolates were detected among the isolates. Overall, a total of 6 genotypes were identified among VISA strains and the predominant clones were ST5-II-t2460, ST72-IV-t324, and ST239-III-t037 (44.7%, 15.8%, and 10.5%, respectively). Of note, ST72-IV-t324 clones are known to be a typical community-associated MRSA. ST239-IIIt037 strains were more resistant to trimethoprim-sulfamethoxazole than any other type of strain. ST72- IV-t324 strains were susceptible to all of the antimicrobial agents tested except erythromycin and daptomycin. All of the VISA isolates were susceptible to linezolid and quinupristin-dalfopristin. Conclusion: Although VRSA is still rare, continuous monitoring of VRSA occurrence is needed, as well as VISA prevalence, epidemic clonal shift, and antimicrobial resistance. KCI Citation Count: 0
Author Lee, Kwang-Jun
Kang, Gi Su
Kim, Il-Hwan
Kim, Hwa Su
Yu, Jae-Yon
Park, Chan
Kim, Jung Wook
Lee, Yeong Seon
Yoo, Jae Il
Author_xml – sequence: 1
  givenname: Jung Wook
  surname: Kim
  fullname: Kim, Jung Wook
  organization: Division of Antimicrobial Resistance, Korea National Research Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju, Korea
– sequence: 2
  givenname: Gi Su
  surname: Kang
  fullname: Kang, Gi Su
  organization: Division of Antimicrobial Resistance, Korea National Research Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju, Korea
– sequence: 3
  givenname: Jae Il
  surname: Yoo
  fullname: Yoo, Jae Il
  organization: Division of Antimicrobial Resistance, Korea National Research Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju, Korea
– sequence: 4
  givenname: Hwa Su
  surname: Kim
  fullname: Kim, Hwa Su
  organization: Division of Antimicrobial Resistance, Korea National Research Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju, Korea
– sequence: 5
  givenname: Yeong Seon
  surname: Lee
  fullname: Lee, Yeong Seon
  organization: Division of Antimicrobial Resistance, Korea National Research Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju, Korea
– sequence: 6
  givenname: Jae-Yon
  surname: Yu
  fullname: Yu, Jae-Yon
  organization: Division of Antimicrobial Resistance, Korea National Research Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju, Korea
– sequence: 7
  givenname: Kwang-Jun
  surname: Lee
  fullname: Lee, Kwang-Jun
  organization: Division of Antimicrobial Resistance, Korea National Research Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju, Korea
– sequence: 8
  givenname: Chan
  surname: Park
  fullname: Park, Chan
  organization: Division of Antimicrobial Resistance, Korea National Research Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju, Korea
– sequence: 9
  givenname: Il-Hwan
  surname: Kim
  fullname: Kim, Il-Hwan
  organization: Division of Antimicrobial Resistance, Korea National Research Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju, Korea
BackLink https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002173920$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp1UU1vEzEUtFCRWkrvPfqKxG6fvV82tyiiENHSqglcrRevt5g6dmR7kfan8G-7STkgJN5lnp5m5mk0b8iJD94QcsmgbFjdXC2WtyUH1pZMlnUpxCtyxrkQBTSiOflrPyUXKf2EeWQHXLZn5PdtcEaPDiPdTHvrHyn6nj6YZFNGrw29j2GwziQaBvp9voTdpK0vVj6buDO9xWzoOuP-x-SCDlqPieIYzQzW0y8hGvxwsBtdTnSIYUeRfsVsg0dH12P8Zaxzx0frPPbTe8oBumLOUr0lrwd0yVz8wXPy7frjZvm5uLn7tFoubgrNOJdFswXo6xql6IB1221loDO6A80QBmj7GvoWhdxy3jSmEhLaRlZodM_6jqGoq3Py7sXXx0E9aasC2iM-BvUU1eJhs1KMS84qOXPbF66OIaVoBqVtPqbJEa1TDNShDzX3oQ59KCZVrYSYhfCPcB_tDuP0f8kzswKPog
CitedBy_id crossref_primary_10_1089_mdr_2020_0346
crossref_primary_10_1089_mdr_2018_0069
crossref_primary_10_3390_pathogens10050564
crossref_primary_10_1016_j_jgar_2018_06_018
Cites_doi 10.1016/j.ijantimicag.2010.06.044
10.1371/journal.pone.0073300
10.1016/j.meegid.2013.03.047
10.1093/jac/40.1.135
10.1093/jac/47.4.399
10.1128/AAC.46.7.2155-2161.2002
10.5402/2012/215275
10.1128/AAC.47.10.3040-3045.2003
10.1371/journal.pone.0136082
10.1128/JCM.38.3.1008-1015.2000
10.1093/jac/dkq009
10.1093/jac/dki413
10.1086/513203
10.1016/S1473-3099(13)70136-1
10.1128/JCM.01152-11
10.1016/S0140-6736(13)61219-2
10.1128/JCM.41.12.5442-5448.2003
10.1016/j.ijantimicag.2013.06.004
10.1128/AAC.00904-08
10.1128/AAC.00093-09
10.1128/AAC.00206-09
10.1128/JCM.00582-08
10.1128/JCM.40.11.4060-4067.2002
10.1007/s12275-016-6157-x
10.1128/JCM.42.2.792-799.2004
10.1128/AAC.01316-09
10.1016/S0140-6736(09)61999-1
10.1093/cid/cir935
10.1086/593953
10.1016/j.ijantimicag.2015.03.009
10.1128/JCM.43.3.1187-1192.2005
10.15585/mmwr.mm6437a6
ContentType Journal Article
DBID AAYXX
CITATION
ACYCR
DOI 10.5145/ACM.2016.19.4.88
DatabaseName CrossRef
Korean Citation Index
DatabaseTitle CrossRef
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
EISSN 2288-0585
2288-6850
EndPage 96
ExternalDocumentID oai_kci_go_kr_ARTI_1292139
10_5145_ACM_2016_19_4_88
GroupedDBID 5-W
8JR
8XY
AAYXX
ACYCR
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CITATION
DIK
EF.
GROUPED_DOAJ
ID FETCH-LOGICAL-c1229-5b00d44a987017bb3e07ec70c1a0f06d40d6a89b2255e38906593aecd1d71a843
ISSN 2288-0585
IngestDate Sun Feb 18 03:18:22 EST 2024
Tue Jul 01 04:13:48 EDT 2025
Thu Apr 24 23:10:53 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License http://creativecommons.org/licenses/by-nc/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1229-5b00d44a987017bb3e07ec70c1a0f06d40d6a89b2255e38906593aecd1d71a843
Notes G704-001687.2016.19.4.002
PageCount 9
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_1292139
crossref_citationtrail_10_5145_ACM_2016_19_4_88
crossref_primary_10_5145_ACM_2016_19_4_88
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-12
PublicationDateYYYYMMDD 2016-12-01
PublicationDate_xml – month: 12
  year: 2016
  text: 2016-12
PublicationDecade 2010
PublicationTitle Annals of clinical microbiology
PublicationYear 2016
Publisher 대한임상미생물학회
Publisher_xml – name: 대한임상미생물학회
References Joo (10.5145/ACM.2016.19.4.88_ref32) 2016; 54
Rybak (10.5145/ACM.2016.19.4.88_ref4) 2008; 46
Melo-Cristino (10.5145/ACM.2016.19.4.88_ref12) 2013; 382
Wootton (10.5145/ACM.2016.19.4.88_ref8) 2001; 47
Adam (10.5145/ACM.2016.19.4.88_ref5) 2010; 54
Howden (10.5145/ACM.2016.19.4.88_ref1) 2014; 21
van Hal (10.5145/ACM.2016.19.4.88_ref16) 2012; 54
Garnier (10.5145/ACM.2016.19.4.88_ref10) 2006; 57
Havaei (10.5145/ACM.2016.19.4.88_ref28) 2012; 2012
Chuang (10.5145/ACM.2016.19.4.88_ref30) 2013; 13
Gilot (10.5145/ACM.2016.19.4.88_ref22) 2002; 40
Tenover (10.5145/ACM.2016.19.4.88_ref15) 2007; 44
Hu (10.5145/ACM.2016.19.4.88_ref26) 2013; 8
Harmsen (10.5145/ACM.2016.19.4.88_ref19) 2003; 41
Zhang (10.5145/ACM.2016.19.4.88_ref25) 2015; 10
Walters (10.5145/ACM.2016.19.4.88_ref14) 2015; 64
Koreen (10.5145/ACM.2016.19.4.88_ref20) 2004; 42
DeLeo (10.5145/ACM.2016.19.4.88_ref29) 2010; 375
Sader (10.5145/ACM.2016.19.4.88_ref34) 2009; 53
Richter (10.5145/ACM.2016.19.4.88_ref3) 2011; 49
Oliveira (10.5145/ACM.2016.19.4.88_ref21) 2002; 46
Park (10.5145/ACM.2016.19.4.88_ref31) 2009; 30
Kirby (10.5145/ACM.2016.19.4.88_ref7) 2010; 65
Liu (10.5145/ACM.2016.19.4.88_ref27) 2003; 47
Sun (10.5145/ACM.2016.19.4.88_ref6) 2009; 53
Shutt (10.5145/ACM.2016.19.4.88_ref23) 2005; 43
Bartley (10.5145/ACM.2016.19.4.88_ref11) 2002; 23
Hiramatsu (10.5145/ACM.2016.19.4.88_ref2) 1997; 40
Enright (10.5145/ACM.2016.19.4.88_ref18) 2000; 38
Chung (10.5145/ACM.2016.19.4.88_ref24) 2015; 46
Moravvej (10.5145/ACM.2016.19.4.88_ref13) 2013; 42
Chung (10.5145/ACM.2016.19.4.88_ref17) 2010; 20
Campanile (10.5145/ACM.2016.19.4.88_ref9) 2010; 36
Prakash (10.5145/ACM.2016.19.4.88_ref33) 2008; 52
References_xml – volume: 36
  start-page: 415
  year: 2010
  ident: 10.5145/ACM.2016.19.4.88_ref9
  publication-title: Int J Antimicrob Agents
  doi: 10.1016/j.ijantimicag.2010.06.044
– volume: 8
  start-page: e73300
  year: 2013
  ident: 10.5145/ACM.2016.19.4.88_ref26
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0073300
– volume: 21
  start-page: 575
  year: 2014
  ident: 10.5145/ACM.2016.19.4.88_ref1
  publication-title: Infect Genet Evol
  doi: 10.1016/j.meegid.2013.03.047
– volume: 40
  start-page: 135
  year: 1997
  ident: 10.5145/ACM.2016.19.4.88_ref2
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/40.1.135
– volume: 47
  start-page: 399
  year: 2001
  ident: 10.5145/ACM.2016.19.4.88_ref8
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/47.4.399
– volume: 46
  start-page: 2155
  year: 2002
  ident: 10.5145/ACM.2016.19.4.88_ref21
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.46.7.2155-2161.2002
– volume: 2012
  start-page: 215275
  year: 2012
  ident: 10.5145/ACM.2016.19.4.88_ref28
  publication-title: ISRN Microbiol
  doi: 10.5402/2012/215275
– volume: 20
  start-page: 637
  year: 2010
  ident: 10.5145/ACM.2016.19.4.88_ref17
  publication-title: J Microbiol Biotechnol
– volume: 47
  start-page: 3040
  year: 2003
  ident: 10.5145/ACM.2016.19.4.88_ref27
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.47.10.3040-3045.2003
– volume: 10
  start-page: e0136082
  year: 2015
  ident: 10.5145/ACM.2016.19.4.88_ref25
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0136082
– volume: 38
  start-page: 1008
  year: 2000
  ident: 10.5145/ACM.2016.19.4.88_ref18
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.38.3.1008-1015.2000
– volume: 65
  start-page: 721
  year: 2010
  ident: 10.5145/ACM.2016.19.4.88_ref7
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkq009
– volume: 57
  start-page: 146
  year: 2006
  ident: 10.5145/ACM.2016.19.4.88_ref10
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dki413
– volume: 44
  start-page: 1208
  year: 2007
  ident: 10.5145/ACM.2016.19.4.88_ref15
  publication-title: Clin Infect Dis
  doi: 10.1086/513203
– volume: 13
  start-page: 698
  year: 2013
  ident: 10.5145/ACM.2016.19.4.88_ref30
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(13)70136-1
– volume: 49
  start-page: 4203
  year: 2011
  ident: 10.5145/ACM.2016.19.4.88_ref3
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.01152-11
– volume: 23
  start-page: 480
  year: 2002
  ident: 10.5145/ACM.2016.19.4.88_ref11
  publication-title: Infect Control Hosp Epidemiol
– volume: 382
  start-page: 205
  year: 2013
  ident: 10.5145/ACM.2016.19.4.88_ref12
  publication-title: Lancet
  doi: 10.1016/S0140-6736(13)61219-2
– volume: 41
  start-page: 5442
  year: 2003
  ident: 10.5145/ACM.2016.19.4.88_ref19
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.41.12.5442-5448.2003
– volume: 42
  start-page: 370
  year: 2013
  ident: 10.5145/ACM.2016.19.4.88_ref13
  publication-title: Int J Antimicrob Agents
  doi: 10.1016/j.ijantimicag.2013.06.004
– volume: 52
  start-page: 4528
  year: 2008
  ident: 10.5145/ACM.2016.19.4.88_ref33
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.00904-08
– volume: 53
  start-page: 3162
  year: 2009
  ident: 10.5145/ACM.2016.19.4.88_ref34
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.00093-09
– volume: 53
  start-page: 3642
  year: 2009
  ident: 10.5145/ACM.2016.19.4.88_ref6
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.00206-09
– volume: 46
  start-page: 2950
  year: 2008
  ident: 10.5145/ACM.2016.19.4.88_ref4
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.00582-08
– volume: 40
  start-page: 4060
  year: 2002
  ident: 10.5145/ACM.2016.19.4.88_ref22
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.40.11.4060-4067.2002
– volume: 54
  start-page: 445
  year: 2016
  ident: 10.5145/ACM.2016.19.4.88_ref32
  publication-title: J Microbiol
  doi: 10.1007/s12275-016-6157-x
– volume: 42
  start-page: 792
  year: 2004
  ident: 10.5145/ACM.2016.19.4.88_ref20
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.42.2.792-799.2004
– volume: 54
  start-page: 945
  year: 2010
  ident: 10.5145/ACM.2016.19.4.88_ref5
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.01316-09
– volume: 375
  start-page: 1557
  year: 2010
  ident: 10.5145/ACM.2016.19.4.88_ref29
  publication-title: Lancet
  doi: 10.1016/S0140-6736(09)61999-1
– volume: 54
  start-page: 755
  year: 2012
  ident: 10.5145/ACM.2016.19.4.88_ref16
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cir935
– volume: 30
  start-page: 146
  year: 2009
  ident: 10.5145/ACM.2016.19.4.88_ref31
  publication-title: Infect Control Hosp Epidemiol
  doi: 10.1086/593953
– volume: 46
  start-page: 338
  year: 2015
  ident: 10.5145/ACM.2016.19.4.88_ref24
  publication-title: Int J Antimicrob Agents
  doi: 10.1016/j.ijantimicag.2015.03.009
– volume: 43
  start-page: 1187
  year: 2005
  ident: 10.5145/ACM.2016.19.4.88_ref23
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.43.3.1187-1192.2005
– volume: 64
  start-page: 1056
  year: 2015
  ident: 10.5145/ACM.2016.19.4.88_ref14
  publication-title: MMWR Morb Mortal Wkly Rep
  doi: 10.15585/mmwr.mm6437a6
SSID ssj0000970296
Score 1.9729111
Snippet Background: To investigate the national molecular epidemiology and resistance profiles of vancomycinintermediate Staphylococcus aureus (VISA), we analyzed the...
SourceID nrf
crossref
SourceType Open Website
Enrichment Source
Index Database
StartPage 88
SubjectTerms 임상병리학
Title Molecular Typing and Resistance Profiles of Vancomycin-Intermediate Staphylococcus aureus in Korea: Results from a National Surveillance Study, 2007-2013
URI https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002173920
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Annals of Clinical Microbiology, 2016, 19(4), 19, pp.88-96
journalDatabaseRights – providerCode: PRVAON
  databaseName: Openly Available Collection - DOAJ
  customDbUrl:
  eissn: 2288-0585
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000970296
  issn: 2288-0585
  databaseCode: DOA
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2288-0585
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000970296
  issn: 2288-0585
  databaseCode: DIK
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVERR
  databaseName: KoreaMed Open Access
  customDbUrl:
  eissn: 2288-0585
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000970296
  issn: 2288-0585
  databaseCode: 5-W
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://koreamed.org/journals
  providerName: Korean Association of Medical Journal Editors
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF615cIFgQBRXlohfEDBqR9re5eb46YqoFRItKg3a22vq6itjZIYCf4J_5aZXTt2ohYVLtZosg8n32fP7GZ2hpC3mWJFGajQBlumbMac3OZlFtheIcPCyXxR6GjC2Ul4fMY-nQfnO7vxIGqpWWXj_NeN50r-B1XQAa54SvYfkF0PCgqQAV-4AsJwvRPGs6627QiWk_1pwyX6hPjAfjEFuXW0xjfQ1Nc_83ll611AfWRkhYGEmLEaTFqd581yJJuFanSM7Oca_EkTL7dsrlZLcxJFjk667cOvzeKHwqJFOpsnpqlFvPSuJNh7f-j29mma1ycxr-d9CqgOdWsaWxOBwRfTxIodSwQoCFC6G03MJyBwlKEJ55bgfRPoo_ujMLXiRAuH1iS5YaJDSwhLsM1R2m0QN9wKKbGmE4snXb8ApzFzcDOAD445tomP8N6MBiZGTQLTd72EFmIYqn8Pex7QzglMZaGx6nUhNzlz23e_KU_YehGmTO-2fQLvFFN5xMkMgwrDsSvGbNz1G6YC3zLRG8nAL_N5elGnl4sUljwfU3DYPHDjd8k9DwybM9hV0M6IiBxPV6lbfw3zZz3eysH2jWw4Z7vVohz4WqcPyYN2kURjw_hHZEdVj8nvNdupYTsFttOe7bRjO61Legvb6SbbqWE7nVdUs_0DbblOketU0o7rdMh1qrn-nq6Z_oScHU1Pk2O7LSxi567nCTsAW1MwJgUYKzfKMl85kcojJ3elUzphwZwilFxkYOsCBR49xh74UuWFW0Su5Mx_SvaqulLPCI14yfxIZiFTJYskkwBHoUpYssIrumRqnxx0v2iat1n3sfjLVQqrb8QgBQxSxCB1RcpSzvfJu3WP7ybjzF_avgGQNCNuZ8bzuzR6Qe73T9VLsrdaNOoVuNur7LUm1B8Rlr8j
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Molecular+Typing+and+Resistance+Profiles+of+Vancomycin-Intermediate+Staphylococcus+aureus+in+Korea%3A+Results+from+a+National+Surveillance+Study%2C+2007-2013&rft.jtitle=Annals+of+clinical+microbiology&rft.au=%EA%B9%80%EC%A0%95%EC%9A%B1&rft.au=%EA%B0%95%EA%B8%B0%EC%88%98&rft.au=%EC%9C%A0%EC%9E%AC%EC%9D%BC&rft.au=%EA%B9%80%ED%99%94%EC%88%98&rft.date=2016-12-01&rft.pub=%EB%8C%80%ED%95%9C%EC%9E%84%EC%83%81%EB%AF%B8%EC%83%9D%EB%AC%BC%ED%95%99%ED%9A%8C&rft.issn=2288-0585&rft.eissn=2288-6850&rft.spage=88&rft.epage=96&rft_id=info:doi/10.5145%2FACM.2016.19.4.88&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_1292139
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2288-0585&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2288-0585&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2288-0585&client=summon